Skip to content

Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women

Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02205749
Enrollment
302
Registered
2014-07-31
Start date
2013-01-31
Completion date
2015-08-31
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biospecimen Donation

Keywords

biobanks, informed consent, health literacy

Brief summary

Research with stored biospecimens can provide substantial societal benefits, including greater understanding of cancer etiology and discovery of new cancer therapies, but one critical social and ethical issue is the use of samples for research unplanned at the time of biospecimen collection. Various models for consent (i.e., no consent, notice, opt-out, broad consent, study-specific consent) have been proposed for secondary research use of biospecimens, but empirical data on individuals' preferences for different consent models are limited, particularly from those with limited health literacy and from racial and ethnic minority groups. It is critically important to understand the consent preferences of diverse individuals, as participation of all population subgroups in biobanks is essential to reach translational cancer research goals. Based on a social ecological conceptual framework, the investigators will examine preferences for consent models for secondary research uses of biospecimens among a racially and socioeconomically diverse sample of women 35 years of age and older. The investigators aim to compare experimentally the effect of consent model on intentions to donate biospecimens for future research use among a diverse sample of women. The investigators hypothesize that women will have stronger intentions to donate based on the broad model of consent and the study-specific model of consent compared with the notice model of consent. These findings from groups underrepresented in research will be critical since the participation of these groups in biobanks is essential to generating findings that will achieve translational research goals of eliminating cancer disparities.

Interventions

BEHAVIORALStudy-specific consent model

• Review plain language brochure describing consent to a biobank based on the study-specific model of consent

BEHAVIORALBroad consent model

• Review plain language brochure describing consent to a biobank based on the broad model of consent

BEHAVIORALNotice consent model

• Review plain language brochure describing consent to a biobank based on the notice model of consent

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 35 years old or older * Proficient in English * Identifies as Non-Hispanic * Identifies as African-American or Black * Identifies as Caucasian or White * Identifies as Female

Exclusion criteria

* Under 35 years old * Not proficient in English * Identifies as Hispanic * Identifies as a race other than African-American or Black; or Caucasian or White * Identifies as more than one race * Identifies as Male

Design outcomes

Primary

MeasureTime frameDescription
Intent to DonateImmediateIntention to donate to a biobank.

Secondary

MeasureTime frameDescription
Consent Model PreferenceImmediatePreferred type of consent for secondary use of biospecimens.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026